Stakeholder views of managed entry agreements: A literature review of national studies

Access to highly expensive and innovative medicine is a challenge. Managed entry agreements/ arrangements (MEAs) consist of various forms of confidential agreements between pharmaceutical manufacturers and payers (hospitals, social insurance), which are mainly negotiated when there is uncertainty of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanimalai, Subramaniam, Choon, Wai Yee, Lee, Kenneth Kwing-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297797/
https://www.ncbi.nlm.nih.gov/pubmed/37383516
http://dx.doi.org/10.1016/j.hpopen.2021.100032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297797/
https://www.ncbi.nlm.nih.gov/pubmed/37383516
http://dx.doi.org/10.1016/j.hpopen.2021.100032

Ejemplares similares